ArticleMolecular therapy. Nucleic acids2025

Antisense oligonucleotide therapy for patients with Friedreich's ataxia carrying the c.165+5G>C splicing mutation.

Pouiré Yameogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.